Association between NQO1 Pro187Ser polymorphism and esophageal cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2063-2068

  Liu, Kai ^a   Tian, Hui ^a   Yu, Kai Zhong ^a   Shen, Wei Yu ^a   Mao, Zhen Chun ^a   Jin, Chen Hua ^a   Pan, Hai Bin ^a   He, Jin Xian ^a  

^a Ningbo Medical Center and Li Huili Hospital   (China)

Author keywords

Esophageal cancer; Meta analysis; NQO1; Polymorphism

Indexed keywords

HYDROQUINONE DERIVATIVE; PROLINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SERINE;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; ENZYME ACTIVITY; ENZYME MECHANISM; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMOZYGOTE; HUMAN; NQO1 GENE; ONCOGENE; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899049374     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1273-2     Document Type: Article

References (27)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349:2241-52.
2. Fitzgerald RC. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810-20.
3. Maley CC. Open questions in oesophageal adenocarcinogenesis. Gut. 2007;56:897-8.
4. Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev. 2010;20:210-7.
5. Dinkova-Kostova AT, Talalay P. NAD(P)H:Quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010;501:116-23.
6. Siegel D, Yan C, Ross D. NAD(P)H:Quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol. 2012;83:1033-40.
7. Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: a huge review and meta-analysis. Am J Epidemiol. 2008;168:1221-32.
8. Dougherty D, Garte S, Barchowsky A, Zmuda J, Taioli E. NQO1, MPO, CYP2E1, GSTT1 and GSTM1 polymorphisms and biological effects of benzene exposure - a literature review. Toxicol Lett. 2008;182:7-17.
9. Yang FY, Guan QK, Cui YH, Zhao ZQ, Rao W, Xi Z. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies. Eur J Cancer Prev. 2012;21:432-41.
10. Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7:103-8.
11. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, et al. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a german caucasian and a northern chinese population. Carcinogenesis. 2003;24:905-9.
12. Zhang JH, Li Y, Wang R, Sarbia M, Guo W, Wen DG, et al. The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003;20:544-6.
13. von Rahden BH, Stein HJ, Langer R, von Weyhern CW, Schenk E, Doring C, et al. C609t polymorphism of the NAD(P)H: quinone oxidoreductase i gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer. 2005;113:506-8.
14. Feng X, Li Z, Wang L, Zhang J, Lu Z. Study on the relationship between polymorphisms of NQO1 gene and susceptibility to esophageal cancer. Chinese journal of disease control & prevention. 2008;12:112-4.
15. Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from iran. Genet Mol Res. 2010;9:239-49.
16. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Null association of NQO1 609C > T and NQO2-3423G > A polymorphisms with susceptibility and prognosis of esophageal cancer in north Indian population and meta-analysis. Cancer Epidemiol. 2012;36:e373-379.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
21. Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, et al. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer. 2003;107:381-6.
22. Zhang WC, Yin LH, Pu YP, Liang GY, Hu X, Liu YZ, et al. Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40:324-7.
23. Zhou Y, Chen H, Shi X, Zhou Z, Li G, Pan P, et al. A case-control study on the polymorphisms of NQO1 and susceptibility of esophageal cancer. Bulletin of Chinese cancer. 2006;15:659-63.
24. di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, et al. The NAD(P)H: quinone oxidoreductase i C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med. 2007;9:341-7.
25. Malik MA, Zargar SA, Mittal B. Role of NQO1 609C > T and NQO2-3423 G > A gene polymorphisms in esophageal cancer risk in Kashmir Valley and meta analysis. Mol Biol Rep. 2012;39:9095-104.
26. Lajin B, Alachkar A. The NQO1 polymorphism C609T (pro187ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer 2013. 2013. doi: 10.1038/bjc.2013.357.
27. Wang Y, Zhang G, Luo Y. Association between NQO1 C609T polymorphism and colorectal cancer risk. Tumour Biol. 2013. doi: 10.1007/s13277-013-0993-7.